Elliot J Stein, Colin Neill, Sangeeta Nair, J Greg Terry, J Jeffrey Carr, William F Fearon, Sammy Elmariah, Juyong B Kim, Samir Kapadia, Dharam J Kumbhani, Linda Gillam, Brian Whisenant, Nishath Quader, Alan Zajarias, Frederick G Welt, Anthony A Bavry, Megan Coylewright, Robert Piana, Ravinder R Mallugari, Anna Vatterott, Natalie Jackson, Shi Huang, Brian R Lindman
BACKGROUND: Frailty associates with worse outcomes after transcatheter aortic valve replacement (TAVR). Sarcopenia underlies frailty, but the association between a comprehensive assessment of sarcopenia-muscle mass, strength, and performance-and outcomes after TAVR has not been examined. METHODS: From a multicenter prospective registry of patients with symptomatic severe aortic stenosis undergoing TAVR, 445 who had a preprocedure computed tomography and clinical assessment of frailty were included...
January 18, 2024: Circulation. Cardiovascular Interventions